Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS oncology.

I W Flinn1, R F Ambinder

  • 1Johns Hopkins Oncology Center, Baltimore, Maryland 21231, USA.

Current Opinion in Infectious Diseases
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

New diagnostic methods may avoid brain biopsies for primary central nervous system lymphoma. Advances include reduced-dose chemotherapy for non-Hodgkin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients.

Cancer chemotherapy and pharmacology·2017
Same author

Rituximab: a benchmark in the development of chemotherapy-free treatment strategies for follicular lymphomas.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial.

Leukemia·2016
Same author

Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up.

Leukemia·2012
Same author

A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors.

Oncogene·2011
Same journal

Use of gloves: current evidence vs. current use.

Current opinion in infectious diseases·2026
Same journal

Understanding challenges to prevention of healthcare related infections.

Current opinion in infectious diseases·2026
Same journal

Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts.

Current opinion in infectious diseases·2026
Same journal

Epidemiology, treatment and outcomes of antimicrobial-resistant infections in hematopoietic stem cell transplant recipients.

Current opinion in infectious diseases·2026
Same journal

Dengue and chikungunya vaccines past, present and future: implications for travelers.

Current opinion in infectious diseases·2026
Same journal

Oropouche virus: viral evolution, epidemiological trends, and challenges for control.

Current opinion in infectious diseases·2026
See all related articles

Area of Science:

  • Oncology
  • Hematology
  • Immunology

Background:

  • Primary central nervous system lymphoma (PCNSL) diagnosis often requires invasive brain biopsy.
  • Non-Hodgkin's lymphoma (NHL) treatment protocols are evolving.
  • Kaposi's sarcoma (KS) and Epstein-Barr virus (EBV)-associated lymphomas present ongoing therapeutic challenges.

Purpose of the Study:

  • To review recent advancements in the diagnosis and treatment of various lymphomas and related conditions.
  • To highlight non-invasive diagnostic strategies for PCNSL.
  • To discuss novel therapeutic agents and approaches for hematologic malignancies and viral-associated B-cell lymphomas.

Main Methods:

  • Review of recent literature on diagnostic techniques for PCNSL.
  • Analysis of randomized controlled trials for reduced-dose chemotherapy in NHL.

Related Experiment Videos

  • Summary of emerging treatments for Kaposi's sarcoma.
  • Evaluation of adoptive cellular immunotherapy for EBV-associated B-cell lymphomas.

    • Main Results:

    • Novel diagnostic approaches may obviate the need for brain biopsy in many PCNSL cases.
    • Reduced-dose chemotherapy demonstrated advantages in a randomized controlled trial for NHL.
    • New therapeutic agents are available for Kaposi's sarcoma treatment.
    • Adoptive cellular immunotherapy shows efficacy in preventing and treating EBV-associated B-cell lymphomas post-bone marrow transplant.

    Conclusions:

    • Diagnostic strategies for PCNSL are improving, potentially reducing invasive procedures.
    • Chemotherapy regimens for NHL are being refined for better outcomes.
    • Therapeutic options for Kaposi's sarcoma have expanded.
    • Cellular immunotherapy holds promise for managing specific B-cell lymphomas, particularly in immunocompromised patients.